Related Experiment Video

Updated: Aug 14, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Tuberculosis in children from the Sverdlovsk Region]

O B Nechaeva, G G Popkova, E I Skachkova

    Problemy Tuberkuleza I Boleznei Legkikh
    |April 2, 2005
    PubMed

    Insights

    BCG vaccination significantly reduces tuberculosis risk in infants. A larger vaccination scar indicates better protection, while technological failures are linked to complications.

    Area of Science:

    • Pediatrics
    • Immunology
    • Infectious Diseases

    Background:

    • Tuberculosis remains a significant global health threat, particularly for infants.
    • Bacillus Calmette-Guérin (BCG) vaccination is a primary preventive measure against severe forms of tuberculosis in children.
    • Assessing the efficacy and safety of BCG vaccination is crucial for public health strategies.

    Purpose of the Study:

    • To evaluate the impact of BCG vaccination on tuberculosis morbidity in infants.
    • To determine the correlation between BCG vaccination scar size and protection against tuberculosis.
    • To identify the primary causes of complications associated with BCG vaccination.

    Main Methods:

    • Comparative analysis of tuberculosis morbidity rates between BCG-vaccinated and unvaccinated infant populations.
    • Correlation study between BCG vaccination scar dimensions and subsequent tuberculosis incidence.
    • Analysis of reported complications to identify technological failures and vaccine-related factors.

    Main Results:

    • BCG-unvaccinated infants exhibit an 18-fold higher tuberculosis morbidity rate compared to vaccinated infants.
    • Infants with absent or small (1-2 mm) BCG scars show a 7-fold increased tuberculosis risk by age 3 compared to those with larger scars (≥3 mm).
    • Technological failures are identified as the predominant cause of BCG vaccination complications, irrespective of the vaccine type (BCG-1 or BCG-M).

    Conclusions:

    • BCG vaccination is highly effective in reducing tuberculosis morbidity in infants.
    • The size of the BCG vaccination scar serves as a reliable indicator of vaccine efficacy and protection.
    • Improving vaccination technology and procedures is essential to minimize BCG-related complications.

    More Related Videos

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

    Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

    Published on: September 7, 2022

    Related Concept Videos

    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Tuberculosis01:23

    Tuberculosis

    Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...